In Japan, clinical trials of a vaccine against COVID-19 starts June 30

Clinical trials of a vaccine against coronavirus COVID-19, which was developed by one of the medical companies in Japan, will begin in late June, said Wednesday on a press-conferences the Governor of Osaka Hirofumi Yoshimura.

"We made progress in developing a vaccine against the new coronavirus created in Japan, established in Osaka, and its human trials will be conducted in the end of the month, June 30," said the Governor.

According to him, this will be the first test in Japan of a vaccine against coronavirus in humans.

World health organization March 11 announced the outbreak of a new coronavirus infection COVID-19 pandemic. According to the latest who data, the world revealed more than 7.9 million infections, over 434 thousand people died.

Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.